Severe autoimmune thrombocytopenic purpura during interferon-α therapy for chronic myelogenous leukemia

Acta Haematologica

Volumn 112, Issue 4, 2004, Pages 217-218

  Arimura, Kosei ^a   Arima, Naomichi ^a,b   Ohtsubo, Hideo ^a   Matsushita, Kakushi ^a   Kukita, Toshimasa ^a   Ayukawa, Tomoko ^c   Kuroki, Tomoaki ^c   Tei, Chuwa ^c  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adverse effects; Autoimmune thrombocytopenia; Chronic myelogenous leukemia; Interferon ; Thrombocytopenia

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING TENDENCY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; PETECHIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; PIPERAZINES; PREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PYRIMIDINES; REMISSION INDUCTION;

EID: 9144242253     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081276     Document Type: Article

References (9)

1. Raanani P, Ben-Bassat I: Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 2002;107:133-144.
2. Interferon alpha-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. N Engl J Med 1994;330:820-825.
3. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM: Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med 1991;114:532-538.
4. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU: Clinical toxicity of interferons in cancer patients: A review. J Clin Oncol 1986;4:234-243.
5. Conlon KC, Urba WJ, Smith JW 2nd, Steis RG, Longo DL, Clark JW: Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990;65:2237-2242.
6. Ronnblom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115:178-183.
7. D'Hondt L, Delannoy A, Docquier C: Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 1993;12:415-417.
8. McLaughlin P, Talpaz M, Quesada JR, Saleem A, Barlogie B, Gutterman JU: Immune thrombocytopenia following alpha-interferon therapy in patients with cancer. JAMA 1985;254:1353-1354.
9. Zuffa E, Vianelli N, Martinelli G, Tazzari P, Cavo M, Tura S: Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia. Haematologica 1996;81:533-535.